{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T15:01:26Z","timestamp":1795186886281,"version":"4.10.3"},"reference-count":174,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["FRGS\/1\/2022\/SKK10\/SYUC\/02\/4"],"award-info":[{"award-number":["FRGS\/1\/2022\/SKK10\/SYUC\/02\/4"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.biopha.2025.117827","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T18:52:24Z","timestamp":1737658344000},"page":"117827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["The role of mitochondrial dysfunction in Huntington\u2019s disease: Implications for therapeutic targeting"],"prefix":"10.1016","volume":"183","author":[{"given":"Deepak Chandra","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuri Bapu","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajal","family":"Gurow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagjit Singh","family":"Dhaliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long Chiau","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.117827_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/ene.13413","article-title":"Huntington\u2019s disease: a clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.biopha.2025.117827_bib2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000443738","article-title":"The prevalence of Huntington\u2019s disease","volume":"46","author":"Rawlins","year":"2016","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.biopha.2025.117827_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.117827_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-08927-0_9","article-title":"Molecular genetics of Huntington\u2019s disease","volume":"822","author":"Bobori","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.biopha.2025.117827_bib5","doi-asserted-by":"crossref","DOI":"10.1007\/s12640-017-9766-1","article-title":"Huntington\u2019s disease and mitochondria","volume":"32","author":"Jodeiri Farshbaf","year":"2017","journal-title":"Neurotox. Res"},{"key":"10.1016\/j.biopha.2025.117827_bib6","doi-asserted-by":"crossref","DOI":"10.1080\/15548627.2020.1728096","article-title":"Mutant HTT (huntingtin) impairs mitophagy in a cellular model of Huntington disease","volume":"17","author":"Franco-Iborra","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2025.117827_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2009.07.010","article-title":"Role of mitochondrial dysfunction in the pathogenesis of Huntington\u2019s disease","volume":"80","author":"Quintanilla","year":"2009","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.biopha.2025.117827_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2008.10.010","article-title":"Mitochondria in neuroplasticity and neurological disorders","volume":"60","author":"Mattson","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2025.117827_bib9","first-page":"4","article-title":"Huntington\u2019s disease prevalence in Asia: a systematic review and meta-analysis","volume":"59","author":"Papanna","year":"2024","journal-title":"Riv. Psichiatr"},{"key":"10.1016\/j.biopha.2025.117827_bib10","doi-asserted-by":"crossref","DOI":"10.1192\/bjp.157.4.598","article-title":"Prevalence of Huntington\u2019s disease among UK immigrants from the Indian subcontinent","volume":"157","author":"Shiwach","year":"1990","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.biopha.2025.117827_bib11","doi-asserted-by":"crossref","DOI":"10.1176\/ajp.148.1.132-a","article-title":"Huntington\u2019s disease: a disorder of families","volume":"148","author":"Martin","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.biopha.2025.117827_bib12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1212\/WNL.36.2.244","article-title":"Huntington\u2019s disease in Venezuela: neurologic features and functional decline","volume":"36","author":"Young","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.117827_bib13","article-title":"The prevalence of Huntington\u2019s disease in Tasmania","volume":"153","author":"Pridmore","year":"1990","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.biopha.2025.117827_bib14","doi-asserted-by":"crossref","DOI":"10.1007\/s10072-021-05217-y","article-title":"Geographic differences in the incidence of Huntington\u2019s disease in Sardinia, Italy","volume":"42","author":"Muroni","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.biopha.2025.117827_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-019-1556-3","article-title":"Epidemiology and health care utilization of patients suffering from Huntington\u2019s disease in Germany: Real-world evidence based on German claims data","volume":"19","author":"Ohlmeier","year":"2019","journal-title":"BMC Neurol."},{"key":"10.1016\/j.biopha.2025.117827_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/j.1399-0004.2010.01603.x","article-title":"Huntington\u2019s disease in Greece: the experience of 14 years","volume":"80","author":"Panas","year":"2011","journal-title":"Clin. Genet"},{"key":"10.1016\/j.biopha.2025.117827_bib17","doi-asserted-by":"crossref","DOI":"10.1159\/000337680","article-title":"An unusually low prevalence of Huntington\u2019s disease in Iceland","volume":"68","author":"Sveinsson","year":"2012","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.biopha.2025.117827_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-021-01699-3","article-title":"Validation of diagnostic codes and epidemiologic trends of Huntington disease: a population-based study in Navarre, Spain","volume":"16","author":"Vicente","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.biopha.2025.117827_bib19","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.embor.7400250","article-title":"Huntingtin and the molecular pathogenesis of Huntington\u2019s disease. Fourth in the molecular medicine review series","volume":"5","author":"Landles","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.biopha.2025.117827_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/306234a0","article-title":"A polymorphic DNA marker genetically linked to Huntington\u2019s disease","volume":"306","author":"Gusella","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.117827_bib21","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"Huntington","year":"1993","journal-title":"Huntingt. \u2019S. Dis. Collab. Res. Group. Cell"},{"key":"10.1016\/j.biopha.2025.117827_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.str.2020.06.008","article-title":"The polyglutamine expansion at the N-Terminal of huntingtin protein modulates the dynamic configuration and phosphorylation of the C-terminal HEAT domain","volume":"28","author":"Jung","year":"2020","journal-title":"Structure"},{"key":"10.1016\/j.biopha.2025.117827_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/S0896-6273(03)00594-4","article-title":"Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila","volume":"40","author":"Gunawardena","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2025.117827_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2020.04.001","article-title":"Traffic signaling: new functions of huntingtin and axonal transport in neurological disease","volume":"63","author":"Vitet","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.biopha.2025.117827_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/0092-8674(95)90542-1","article-title":"Targeted disruption of the Huntington\u2019s disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes","volume":"81","author":"Nasir","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.117827_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The biology of huntingtin","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2025.117827_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/ana.26039","article-title":"Age-related cognitive changes as a function of CAG repeat in child and adolescent carriers of mutant huntingtin","volume":"89","author":"Schultz","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biopha.2025.117827_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajhg.2021.12.002","article-title":"Longer CAG repeat length is associated with shorter survival after disease onset in Huntington's disease","volume":"109","author":"Langbehn","year":"2022","journal-title":"Am. J. Hum. Genet"},{"key":"10.1016\/j.biopha.2025.117827_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awae063","article-title":"A CAG repeat threshold for therapeutics targeting somatic instability in Huntington\u2019s disease","volume":"147","author":"Aldous","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2025.117827_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010523","article-title":"Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington\u2019s disease","volume":"6","author":"Lu","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2025.117827_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/ene.13413","article-title":"Huntington\u2019s disease: a clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.biopha.2025.117827_bib32","article-title":"New perspectives on the neuropathology of Huntington\u2019s disease in the human brain and its relation to symptom variation","volume":"1","author":"Waldvogel","year":"2012","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.biopha.2025.117827_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/mds.26011","article-title":"Diagnostic criteria for Huntington\u2019s disease based on natural history","volume":"29","author":"Reilmann","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2025.117827_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington\u2019s disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2025.117827_bib35","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/bpa.12432","article-title":"Cognitive dysfunction in Huntington\u2019s disease: mechanisms and therapeutic strategies beyond BDNF","volume":"26","author":"Puigdell\u00edvol","year":"2016","journal-title":"Brain Pathol."},{"key":"10.1016\/j.biopha.2025.117827_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12101389","article-title":"Pathogenesis of Huntington\u2019s disease: an emphasis on molecular pathways and prevention by natural remedies","volume":"12","author":"Irfan","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.biopha.2025.117827_bib37","doi-asserted-by":"crossref","DOI":"10.1177\/1039856218791036","article-title":"Huntington\u2019s disease: neuropsychiatric manifestations of Huntington\u2019s disease","volume":"26","author":"Goh","year":"2018","journal-title":"Australas. Psychiatry"},{"key":"10.1016\/j.biopha.2025.117827_bib38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3233\/JHD-230576","article-title":"Sleep disorders and circadian disruption in Huntington\u2019s disease","volume":"12","author":"Saade-Lemus","year":"2023","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.biopha.2025.117827_bib39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.nbd.2019.02.002","article-title":"Olfactory bulb atrophy and caspase activation observed in the BACHD rat models of Huntington disease","volume":"125","author":"Lessard-Beaudoin","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2025.117827_bib40","article-title":"Eye movement disorders in movement disorders","volume":"9","author":"Kassavetis","year":"2022","journal-title":"Mov. Disord. Clin. Pr."},{"key":"10.1016\/j.biopha.2025.117827_bib41","article-title":"Quantifying the onset of unintended weight loss in Huntington\u2019s disease: a retrospective analysis of enroll-HD","volume":"10","author":"Ogilvie","year":"2021","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.biopha.2025.117827_bib42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/bs.irn.2022.06.005","article-title":"The microbiota-gut-brain axis in Huntington\u2019s disease","volume":"167","author":"Love","year":"2022","journal-title":"Int Rev. Neurobiol."},{"key":"10.1016\/j.biopha.2025.117827_bib43","doi-asserted-by":"crossref","DOI":"10.5603\/JNNS.a2020.0025","article-title":"Sexual dysfunction in Huntington\u2019s disease - a systematic review","volume":"54","author":"Szymus","year":"2020","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.biopha.2025.117827_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12050676","article-title":"Lower prevalence of chronic pain in manifest Huntington\u2019s disease: a pilot observational study","volume":"12","author":"Delussi","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.biopha.2025.117827_bib45","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-014-8715-8","article-title":"Transcription, epigenetics and ameliorative strategies in Huntington\u2019s disease: a genome-wide perspective","volume":"51","author":"Valor","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2025.117827_bib46","doi-asserted-by":"crossref","DOI":"10.54097\/hset.v8i.1171","article-title":"Huntington\u2019s Disease: current therapies and future directions","volume":"8","author":"Sun","year":"2022","journal-title":"Highlights Sci., Eng. Technol."},{"key":"10.1016\/j.biopha.2025.117827_bib47","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-023-03437-1","article-title":"Repressor element-1 binding transcription factor (REST) as a possible epigenetic regulator of neurodegeneration and MicroRNA-based therapeutic strategies","volume":"60","author":"Nassar","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2025.117827_bib48","doi-asserted-by":"crossref","DOI":"10.1111\/j.1471-4159.2010.07122.x","article-title":"Rescue of gene expression by modified REST decoy oligonucleotides in a cellular model of Huntington\u2019s disease","volume":"116","author":"Soldati","year":"2011","journal-title":"J. Neurochem"},{"key":"10.1016\/j.biopha.2025.117827_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/0006-8993(82)90385-7","article-title":"Ornithine aminotransferase in Huntington\u2019s disease","volume":"231","author":"Wong","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2025.117827_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2018.00153","article-title":"Transcriptional dysregulation and post-translational modifications in polyglutamine diseases: from pathogenesis to potential therapeutic strategies","volume":"11","author":"Xiang","year":"2018","journal-title":"Front Mol. Neurosci."},{"key":"10.1016\/j.biopha.2025.117827_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2006.04.011","article-title":"Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin","volume":"23","author":"Jiang","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2025.117827_bib52","article-title":"Thermoregulation in Huntington\u2019S disease","volume":"85","author":"Lu","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.biopha.2025.117827_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-09148-7","article-title":"Ribosomal transcription is regulated by PGC-1alpha and disturbed in Huntington\u2019s disease","volume":"7","author":"Jesse","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.117827_bib54","article-title":"Epigenetic mechanisms involved in Huntington\u2019s disease pathogenesis","volume":"4","author":"Glajch","year":"2015","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.biopha.2025.117827_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105074","article-title":"Epigenetic regulation in Huntington\u2019s disease","volume":"148","author":"Hyeon","year":"2021","journal-title":"Neurochem Int."},{"key":"10.1016\/j.biopha.2025.117827_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00103","article-title":"Mitochondrial dysfunction in huntington\u2019s disease; interplay between HSF1, p53 and PGC-1\u03b1 transcription factors","volume":"13","author":"Intihar","year":"2019","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.biopha.2025.117827_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14405","article-title":"Abnormal degradation of the neuronal stress-protective transcription factor HSF1 in Huntington\u2019s disease","volume":"8","author":"Gomez-Pastor","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.117827_bib58","doi-asserted-by":"crossref","DOI":"10.1007\/s12031-012-9739-z","article-title":"Sp1 regulates human Huntingtin gene expression","volume":"47","author":"Wang","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2025.117827_bib59","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awt355","article-title":"HTT-lowering reverses Huntington\u2019s disease immune dysfunction caused by NF\u03baB pathway dysregulation","volume":"137","author":"Tr\u00e4ger","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2025.117827_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315272","article-title":"Nrf2 pathway in Huntington\u2019s disease (HD): what is its role?","volume":"23","author":"Tucci","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117827_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2021.01.042","article-title":"Tantalizing role of p53 molecular pathways and its coherent medications in neurodegenerative diseases","volume":"172","author":"Talebi","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2025.117827_bib62","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddt499","article-title":"MeCP2: a novel huntingtin interactor","volume":"23","author":"McFarland","year":"2014","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2025.117827_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroscience.2011.08.052","article-title":"Pathophysiology of Huntington\u2019s disease: time-dependent alterations in synaptic and receptor function","volume":"198","author":"Raymond","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2025.117827_bib64","article-title":"Triheteromeric NMDA receptors: from structure to synaptic physiology","volume":"2","author":"Stroebel","year":"2018","journal-title":"Curr. Opin. Physiol."},{"key":"10.1016\/j.biopha.2025.117827_bib65","doi-asserted-by":"crossref","DOI":"10.1006\/exnr.1999.7135","article-title":"NMDA and non-NMDA receptor-mediated excitotoxicity are potentiated in cultured striatal neurons by prior chronic depolarization","volume":"159","author":"Chen","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2025.117827_bib66","article-title":"Differential changes in postsynaptic density proteins in postmortem Huntington\u2019s disease and Parkinson\u2019s disease human brains","volume":"2014","author":"Fourie","year":"2014","journal-title":"J. Neurodegener. Dis."},{"key":"10.1016\/j.biopha.2025.117827_bib67","first-page":"56","article-title":"Protein homeostasis dysregulation in pathogenesis of neurodegenerative diseases","author":"Kukharsky","year":"2022","journal-title":"Mol. Biol."},{"key":"10.1016\/j.biopha.2025.117827_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03509-0","article-title":"A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers","volume":"9","author":"Thibaudeau","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.117827_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105248","article-title":"The ubiquitin-proteasome system and its crosstalk with mitochondria as therapeutic targets in medicine","volume":"163","author":"Kodro\u0144","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2025.117827_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.it.2015.04.007","article-title":"The choreography of neuroinflammation in Huntington\u2019s disease","volume":"36","author":"Crotti","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biopha.2025.117827_bib71","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-016-3324-6","article-title":"Current status of PET imaging in Huntington\u2019s disease","volume":"43","author":"Pagano","year":"2016","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"10.1016\/j.biopha.2025.117827_bib72","doi-asserted-by":"crossref","DOI":"10.1097\/WNR.0b013e32832e34ee","article-title":"Distinct neuroinflammatory profile in post-mortem human Huntington\u2019s disease","volume":"20","author":"Silvestroni","year":"2009","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopha.2025.117827_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2017.00193","article-title":"Microglial activation in the pathogenesis of Huntington\u2019s disease","volume":"9","author":"Yang","year":"2017","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.biopha.2025.117827_bib74","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-021-02147-6","article-title":"Human Huntington\u2019s disease pluripotent stem cell-derived microglia develop normally but are abnormally hyper-reactive and release elevated levels of reactive oxygen species","volume":"18","author":"O\u2019Regan","year":"2021","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2025.117827_bib75","article-title":"CB2 receptor in microglia: the guardian of self-control","volume":"22","author":"Komorowska-M\u00fcller","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117827_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111847","article-title":"Insights into the pathogenesis of neurodegenerative diseases: focus on mitochondrial dysfunction and oxidative stress","volume":"22","author":"Jurcau","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117827_bib77","article-title":"Deciphering the role of PGC-1 in neurological disorders: from mitochondrial dysfunction to synaptic failure","volume":"17","author":"Panes","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.biopha.2025.117827_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2016.07.122","article-title":"Mitochondrial Ca2+\u2009handling in Huntington\u2019s and Alzheimer\u2019s diseases \u2013 role of ER-mitochondria crosstalk","volume":"483","author":"Naia","year":"2017","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.biopha.2025.117827_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249521","article-title":"Molecular dysfunctions of mitochondria-associated membranes (Mams) in alzheimer\u2019s disease","volume":"21","author":"Eysert","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117827_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2023.10.002","article-title":"Mitochondrial dysfunction in neurodegenerative disorders","volume":"21","author":"Klemmensen","year":"2024","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biopha.2025.117827_bib81","doi-asserted-by":"crossref","DOI":"10.4103\/1673-5374.360289","article-title":"Mitochondria in Huntington\u2019s disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies","volume":"18","author":"Jurcau","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.biopha.2025.117827_bib82","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100067R","article-title":"Mitochondrial fusion and fission: the fine-tune balance for cellular homeostasis","volume":"35","author":"Adebayo","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2025.117827_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13668-3","article-title":"Mitochondrial TCA cycle metabolites control physiology and disease","volume":"11","author":"Mart\u00ednez-Reyes","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.117827_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2016.09.065","article-title":"Energy defects in Huntington\u2019s disease: why \u201cin vivo\u201d evidence matters","volume":"483","author":"Liot","year":"2017","journal-title":"Biochem Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2025.117827_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.tins.2022.12.001","article-title":"Mitochondrial signalling and homeostasis: from cell biology to neurological disease","volume":"46","author":"Collier","year":"2023","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.biopha.2025.117827_bib86","doi-asserted-by":"crossref","DOI":"10.4103\/1673-5374.360289","article-title":"Mitochondria in Huntington\u2019s disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies","volume":"18","author":"Jurcau","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.biopha.2025.117827_bib87","doi-asserted-by":"crossref","DOI":"10.1038\/nrn3570","article-title":"Choosing an animal model for the study of Huntington\u2019s disease","volume":"14","author":"Pouladi","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.biopha.2025.117827_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00342","article-title":"Mitochondrial quality control in neurodegenerative diseases: focus on Parkinson\u2019s disease and Huntington\u2019s disease","volume":"12","author":"Franco-Iborra","year":"2018","journal-title":"Front Neurosci."},{"key":"10.1016\/j.biopha.2025.117827_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2010.09.019","article-title":"Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network","volume":"1813","author":"Scarpulla","year":"2011","journal-title":"Biochim Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.biopha.2025.117827_bib90","article-title":"Insight into the emerging role of striatal neurotransmitters in the pathophysiology of Parkinson\u2019s disease and Huntington\u2019s disease: a review","volume":"17","author":"Jamwal","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.biopha.2025.117827_bib91","doi-asserted-by":"crossref","DOI":"10.1126\/science.abl5163","article-title":"Impact of neurodegenerative diseases on human adult hippocampal neurogenesis","volume":"374","author":"Terreros-Roncal","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.biopha.2025.117827_bib92","doi-asserted-by":"crossref","DOI":"10.1007\/s11011-018-0308-1","article-title":"Mitochondrial alterations accompanied by oxidative stress conditions in skin fibroblasts of Huntington\u2019s disease patients","volume":"33","author":"J\u0119drak","year":"2018","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.biopha.2025.117827_bib93","doi-asserted-by":"crossref","DOI":"10.2217\/nmt-2019-0033","article-title":"Mitochondrial biology and the identification of biomarkers of Huntington\u2019s disease","volume":"10","author":"Neueder","year":"2020","journal-title":"Neurodegener. Dis. Manag"},{"key":"10.1016\/j.biopha.2025.117827_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112480","article-title":"Altered aconitase 2 activity in huntington\u2019s disease peripheral blood cells and mouse model striatum","volume":"18","author":"Chen","year":"2017","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117827_bib95","article-title":"Oxygen consumption deficit in Huntington disease mouse brain under metabolic stress","volume":"25","author":"Lou","year":"2016","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2025.117827_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.freeradbiomed.2020.10.022","article-title":"NRF2 activation by reversible KEAP1 binding induces the antioxidant response in primary neurons and astrocytes of a Huntington\u2019s disease mouse model","volume":"162","author":"Moretti","year":"2021","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.biopha.2025.117827_bib97","article-title":"Iron accumulates in Huntington\u2019s disease neurons: protection by deferoxamine","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.117827_bib98","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddm138","article-title":"Huntingtin-deficient zebrafish exhibit defects in iron utilization and development","volume":"16","author":"Lumsden","year":"2007","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2025.117827_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228765","article-title":"Ferroptosis mechanisms involved in neurodegenerative diseases","volume":"21","author":"Reichert","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117827_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2015.08.006","article-title":"Calcium signaling and cell proliferation","volume":"27","author":"Pinto","year":"2015","journal-title":"Cell Signal"},{"key":"10.1016\/j.biopha.2025.117827_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239153","article-title":"The role of mitochondrial calcium homeostasis in alzheimer\u2019s and related diseases","volume":"21","author":"Ryan","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117827_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2012.10.107","article-title":"Calcium leak through ryanodine receptor is involved in neuronal death induced by mutant huntingtin","volume":"429","author":"Suzuki","year":"2012","journal-title":"Biochem Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2025.117827_bib103","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M504749200","article-title":"Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin","volume":"280","author":"Milakovic","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.117827_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2018.00381","article-title":"Huntingtin-associated protein 1A regulates store-operated calcium entry in medium spiny neurons from transgenic YAC128 mice, a model of Huntington\u2019s disease","volume":"12","author":"Czeredys","year":"2018","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.biopha.2025.117827_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2013.00042","article-title":"Expression of genes encoding the calcium signalosome in cellular and transgenic models of Huntington\u2019s disease","volume":"6","author":"Czeredys","year":"2013","journal-title":"Front Mol. Neurosci."},{"key":"10.1016\/j.biopha.2025.117827_bib106","doi-asserted-by":"crossref","DOI":"10.1111\/cns.12817","article-title":"Cause or compensation?\u2014Altered neuronal Ca2+\u2009handling in Huntington\u2019s disease","volume":"24","author":"Mackay","year":"2018","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.biopha.2025.117827_bib107","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1038-15.2016","article-title":"Enhanced store-operated calcium entry leads to striatal synaptic loss in a huntington\u2019s disease mouse model","volume":"36","author":"Wu","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2025.117827_bib108","doi-asserted-by":"crossref","DOI":"10.4161\/pri.23581","article-title":"Neuronal Ca2+\u2009dyshomeostasis in Huntington disease","volume":"7","author":"Giacomello","year":"2013","journal-title":"Prion"},{"key":"10.1016\/j.biopha.2025.117827_bib109","doi-asserted-by":"crossref","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biopha.2025.117827_bib110","article-title":"Oxidative metabolism and Ca2+\u2009handling in isolated brain mitochondria and striatal neurons from R6\/2 mice, a model of Huntington\u2019s disease","volume":"25","author":"Hamilton","year":"2016","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2025.117827_bib111","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M709555200","article-title":"Impaired regulation of brain mitochondria by extramitochondrial Ca 2+\u2009in transgenic huntington disease rats","volume":"283","author":"Gellerich","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.117827_bib112","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-genet-110410-132529","article-title":"Fusion and fission: Interlinked processes critical for mitochondrial health","volume":"46","author":"Chan","year":"2012","journal-title":"Annu Rev. Genet"},{"key":"10.1016\/j.biopha.2025.117827_bib113","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-57193-5_4","article-title":"Huntington\u2019s disease: pathogenic mechanisms and therapeutic targets","volume":"15","author":"Wright","year":"2017","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.biopha.2025.117827_bib114","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddr024","article-title":"Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington\u2019s disease: implications for selective neuronal damage","volume":"20","author":"Shirendeb","year":"2011","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2025.117827_bib115","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddn404","article-title":"Effects of overexpression of Huntingtin proteins on mitochondrial integrity","volume":"18","author":"Wang","year":"2009","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2025.117827_bib116","doi-asserted-by":"crossref","DOI":"10.1089\/ars.2012.4928","article-title":"S-nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in huntington\u2019s disease","volume":"19","author":"Haun","year":"2013","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.biopha.2025.117827_bib117","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.27866","article-title":"Dynamin-related protein 1: a critical protein in the pathogenesis of neural system dysfunctions and neurodegenerative diseases","volume":"234","author":"Qi","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.biopha.2025.117827_bib118","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.170007","article-title":"Control of mitochondrial biogenesis and function by the ubiquitin - proteasome system","volume":"7","author":"Bragoszewski","year":"2017","journal-title":"Open Biol."},{"key":"10.1016\/j.biopha.2025.117827_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20215338","article-title":"Juvenile huntington\u2019s disease skin fibroblasts respond with elevated parkin level and increased proteasome activity as a potential mechanism to counterbalance the pathological consequences of mutant huntingtin protein","volume":"20","author":"Aladdin","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117827_bib120","article-title":"Mitochondrial fission in Huntington\u2019s disease mouse striatum disrupts ER-mitochondria contacts leading to disturbances in Ca2+\u2009efflux and Reactive Oxygen Species (ROS) homeostasis. N","volume":"136","author":"Cherubini","year":"2020","journal-title":"Eur. Dis."},{"key":"10.1016\/j.biopha.2025.117827_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105240","article-title":"Molecular mechanisms of mitophagy and its roles in neurodegenerative diseases","volume":"163","author":"Li","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2025.117827_bib122","doi-asserted-by":"crossref","DOI":"10.1038\/s41556-018-0176-2","article-title":"Mechanisms of mitophagy in cellular homeostasis, physiology and pathology","volume":"20","author":"Palikaras","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2025.117827_bib123","doi-asserted-by":"crossref","DOI":"10.1038\/ncb2979","article-title":"Cargo recognition and trafficking in selective autophagy","volume":"16","author":"Stolz","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2025.117827_bib124","doi-asserted-by":"crossref","DOI":"10.1038\/embor.2012.14","article-title":"Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment","volume":"13","author":"Greene","year":"2012","journal-title":"EMBO Rep."},{"key":"10.1016\/j.biopha.2025.117827_bib125","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.581","article-title":"PINK1-induced mitophagy promotes neuroprotection in Huntington\u2019s disease","volume":"6","author":"Khalil","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2025.117827_bib126","doi-asserted-by":"crossref","DOI":"10.4161\/auto.6.8.13426","article-title":"p62\/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both","volume":"6","author":"Narendra","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2025.117827_bib127","doi-asserted-by":"crossref","DOI":"10.1038\/nature14879","article-title":"Mechanism of phospho-ubiquitin-induced PARKIN activation","volume":"524","author":"Wauer","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.117827_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2015.08.016","article-title":"The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN\/NDP52 recruitment and TBK1 activation to promote mitophagy","volume":"60","author":"Heo","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biopha.2025.117827_bib129","doi-asserted-by":"crossref","DOI":"10.1038\/nature14893","article-title":"The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy","volume":"524","author":"Lazarou","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.117827_bib130","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2017.00064","article-title":"Neuronal mitophagy in neurodegenerative diseases","volume":"10","author":"Martinez-Vicente","year":"2017","journal-title":"Front Mol. Neurosci."},{"key":"10.1016\/j.biopha.2025.117827_bib131","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M001500200","article-title":"Phorbol esters and cytokines regulate the expression of the NEMO-related protein, a molecule involved in a NF-\u03baB-independent pathway","volume":"275","author":"Schwamborn","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.117827_bib132","doi-asserted-by":"crossref","DOI":"10.1038\/ncb2837","article-title":"Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells","volume":"15","author":"Chu","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2025.117827_bib133","doi-asserted-by":"crossref","DOI":"10.1080\/15548627.2016.1240856","article-title":"Human Atg8-cardiolipin interactions in mitophagy: specific properties of LC3B, GABARAPL2 and GABARAP","volume":"12","author":"Ant\u00f3n","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2025.117827_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2003.12.002","article-title":"The cardiolipin-cytochrome c interaction and the mitochondrial regulation of apoptosis","volume":"423","author":"Iverson","year":"2004","journal-title":"Arch. Biochem Biophys."},{"key":"10.1016\/j.biopha.2025.117827_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2013.11.012","article-title":"Mitochondrial genome changes and neurodegenerative diseases","volume":"1842","author":"Pinto","year":"2014","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2025.117827_bib136","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaa804","article-title":"Mechanisms of replication and repair in mitochondrial DNA deletion formation","volume":"48","author":"Fontana","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2025.117827_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.freeradbiomed.2012.06.008","article-title":"Mitochondrial DNA damage Is associated with reduced mitochondrial bioenergetics in Huntington\u2019s disease","volume":"53","author":"Siddiqui","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2025.117827_bib138","article-title":"ATAD3A oligomerization causes neurodegeneration by coupling mitochondrial fragmentation and bioenergetics defects","volume":"10","author":"Zhao","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.117827_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2016.10.017","article-title":"Mitochondrial cristae remodelling is associated with disrupted OPA1 oligomerisation in the Huntington\u2019s disease R6\/2 fragment model","volume":"288","author":"Hering","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2025.117827_bib140","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awae007","article-title":"Huntington\u2019s disease affects mitochondrial network dynamics predisposing to pathogenic mitochondrial DNA mutations","volume":"147","author":"Neueder","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2025.117827_bib141","doi-asserted-by":"crossref","first-page":"S683","DOI":"10.33549\/physiolres.934712","article-title":"Coenzyme Q10 effects in neurological diseases","volume":"70","author":"Rauchov\u00e1","year":"2021","journal-title":"Physiol. Res."},{"key":"10.1016\/j.biopha.2025.117827_bib142","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000003478","article-title":"A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease","volume":"88","author":"McGarry","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.117827_bib143","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000004209","article-title":"The CREST-E study of creatine for Huntington disease","volume":"89","author":"Hersch","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.117827_bib144","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000001214","article-title":"Triheptanoin improves brain energy metabolism in patients with Huntington disease","volume":"84","author":"Adanyeguh","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.117827_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101195","article-title":"Role of NAD+\u2009in regulating cellular and metabolic signaling pathways","volume":"49","author":"Amjad","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.biopha.2025.117827_bib146","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3390\/ph16111513","article-title":"Huntington\u2019s disease drug development: a phase 3 pipeline analysis","volume":"16","author":"Van de Roovaart","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2025.117827_bib147","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1093\/brain\/awv290","article-title":"Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat","volume":"138","author":"Clemens","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2025.117827_bib148","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.freeradbiomed.2019.11.021","article-title":"The interplay between redox signalling and proteostasis in neurodegeneration: In vivo effects of a mitochondria-targeted antioxidant in Huntington\u2019s disease mice","volume":"146","author":"Pinho","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2025.117827_bib149","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddw045","article-title":"Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington\u2019s disease","volume":"25","author":"Yin","year":"2016","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2025.117827_bib150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/JHD-210510","article-title":"A double-pronged sword: XJB-5-131 is a suppressor of somatic instability and toxicity in Huntington\u2019s disease","volume":"11","author":"Wipf","year":"2022","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.biopha.2025.117827_bib151","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000004209","article-title":"The CREST-E study of creatine for Huntington disease: a randomized controlled trial","volume":"89","author":"Hersch","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.117827_bib152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1878-5085-4-5","article-title":"Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?","volume":"4","author":"M\u00e4hler","year":"2013","journal-title":"EPMA J."},{"key":"10.1016\/j.biopha.2025.117827_bib153","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2991\/efood.k.200203.001","article-title":"Dietary flavonoids in the management of Huntington\u2019s disease: mechanism and clinical perspective","volume":"1","author":"Khan","year":"2020","journal-title":"EFood"},{"key":"10.1016\/j.biopha.2025.117827_bib154","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1750-1326-6-81","article-title":"Dantrolene is neuroprotective in Huntington\u2019s disease transgenic mouse model","volume":"6","author":"Chen","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.biopha.2025.117827_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2010.01.031","article-title":"Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington\u2019s disease mice","volume":"65","author":"Milnerwood","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2025.117827_bib156","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s13311-021-01022-9","article-title":"The sigma-1 receptor mediates pridopidine rescue of mitochondrial function in Huntington Disease models","volume":"18","author":"Naia","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biopha.2025.117827_bib157","doi-asserted-by":"crossref","DOI":"10.1080\/13543784.2020.1804552","article-title":"Huntingtin-lowering strategies for Huntington\u2019s disease","volume":"29","author":"Barker","year":"2020","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.biopha.2025.117827_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2011.04.012","article-title":"Neuronal store-operated calcium entry pathway as a novel therapeutic target for Huntington\u2019s disease treatment","volume":"18","author":"Wu","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.biopha.2025.117827_bib159","doi-asserted-by":"crossref","first-page":"7308","DOI":"10.1093\/hmg\/ddv429","article-title":"Mitochondrial division inhibitor 1 protects against mutant huntingtin-induced abnormal mitochondrial dynamics and neuronal damage in Huntington\u2019s disease","volume":"24","author":"Manczak","year":"2015","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2025.117827_bib160","doi-asserted-by":"crossref","DOI":"10.1172\/JCI70911","article-title":"Inhibition of mitochondrial fragmentation diminishes Huntington\u2019s disease-associated neurodegeneration","volume":"123","author":"Guo","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2025.117827_bib161","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20160776","article-title":"Potential biomarkers to follow the progression and treatment response of huntington\u2019s disease","volume":"213","author":"Disatnik","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2025.117827_bib162","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1016\/j.bbadis.2015.08.012","article-title":"HDAC6 inhibition induces mitochondrial fusion, autophagic flux and reduces diffuse mutant huntingtin in striatal neurons","volume":"1852","author":"Guedes-Dias","year":"2015","journal-title":"Biochim. Et. Biophys. Acta BBA Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2025.117827_bib163","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/hmg\/ddw045","article-title":"Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington\u2019s disease","volume":"25","author":"Yin","year":"2016","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2025.117827_bib164","doi-asserted-by":"crossref","DOI":"10.3727\/096368916X690863","article-title":"Allele-specific reduction of the mutant huntingtin allele using transcription activator-like effectors in human huntington\u2019s disease fibroblasts","volume":"25","author":"Fink","year":"2016","journal-title":"Cell Transpl."},{"key":"10.1016\/j.biopha.2025.117827_bib165","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1206506109","article-title":"Synthetic zinc finger repressors reduce mutant huntingtin expression in the brain of R6\/2 mice","volume":"109","author":"Garriga-Canut","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.117827_bib166","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-022-03150-5","article-title":"CRISPR\/Cas9 mediated therapeutic approach in Huntington\u2019s disease","volume":"60","author":"Alkanli","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2025.117827_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymeth.2017.08.017","article-title":"Stem cell transplantation for Huntington\u2019s diseases","volume":"133","author":"Choi","year":"2018","journal-title":"Methods"},{"key":"10.1016\/j.biopha.2025.117827_bib168","unstructured":"Study Details | Clinical Extension Study for Safety and Efficacy Evaluation of Cellavita-HD Administration in Huntington\u2019s Patients. | ClinicalTrials.gov n.d. \u3008https:\/\/clinicaltrials.gov\/study\/NCT04219241\u3009 (accessed September 23, 2024)."},{"key":"10.1016\/j.biopha.2025.117827_bib169","article-title":"Huntington\u2019s disease clinical trials corner: april 2020","volume":"9","author":"Rodrigues","year":"2020","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.biopha.2025.117827_bib170","article-title":"Amelioration of Huntington\u2019s disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington\u2019s disease monkeys","volume":"14","author":"Cho","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.117827_bib171","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddh162","article-title":"Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release","volume":"13","author":"Choo","year":"2004","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2025.117827_bib172","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddr024","article-title":"Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington\u2019s disease: Implications for selective neuronal damage","volume":"20","author":"Shirendeb","year":"2011","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2025.117827_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.freeradbiomed.2012.06.008","article-title":"Mitochondrial DNA damage Is associated with reduced mitochondrial bioenergetics in Huntington\u2019s disease","volume":"53","author":"Siddiqui","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2025.117827_bib174","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1206506109","article-title":"Synthetic zinc finger repressors reduce mutant huntingtin expression in the brain of R6\/2 mice","volume":"109","author":"Garriga-Canut","year":"2012","journal-title":"Proc. Natl. Acad. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225000216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225000216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:50:21Z","timestamp":1762311021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225000216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":174,"alternative-id":["S0753332225000216"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117827","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of mitochondrial dysfunction in Huntington\u2019s disease: Implications for therapeutic targeting","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117827","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117827"}}